LBIO (Longevity Biomedical) Beneish M-Score


What is Longevity Biomedical Beneish M-Score?

Longevity Biomedical does not have enough data to calculate Beneish M-Score.

Longevity Biomedical Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Longevity Biomedical's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Biomedical Beneish M-Score Chart

Longevity Biomedical Annual Data
Trend
Beneish M-Score

Longevity Biomedical Semi-Annual Data
Beneish M-Score

LBIO vs : Beneish M-Score Comparison

For the Biotechnology subindustry, Longevity Biomedical's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Beneish M-Score falls into.


Longevity Biomedical Business Description

Comparable Companies
Address 12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.